1) High performance (Responsiveness&Specificity): Fusion of responsive PCR technology (Real-time PCR + Nested PCR)
: Tests for 2 types of genes (Multiplex PCR)
: Uses high efficiency enzymes
2) Pollution prevention : Performs PCR twice in one tube
: Applies UDG (Uracil-DNA glycosylase) system
3) Highly stable: Reagent remains stable more than a year after production
Our technology is related to the manufacturing of the reagent used in molecular analysis of tuberculosis, and it is a molecular diagnostic technology that tests for Mycobacterium Tuberculosis (MTB) by utilizing Real-time PCR. This technology possesses relatively high responsiveness and specificity compared to other existing products.
Since even a small amount of MTB is analyzed after going through primary PCR, this product is advantageous in the initial detection of MTB infections and detects even miniscule amounts of MTB. Also, the application of Dual target technology decreased false positive and false negative results significantly. There was no notable statistical difference between the results of Roche COBAS, product with the highest market share both domestically and internationally, and our clinical trial results, which is evidence that there is no difference in quality between our product and the number one product in the world.
More than 10% cheaper compared to other products both domestically and internationally, and extremely competitive due to being more than 100 times more responsive compared to other products in internal test results.